Mount Sinai’s Dr. Scott Friedman Receives Honors at American Association for the Study of Liver Disease Annual Meeting

New York, NY
 – November 21, 2016 /Press Release/  –– 

Scott L. Friedman, MD, Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, received multiple honors at the American Association for the Study of Liver Disease (AASLD) Annual Meeting on November 14, 2016, in Boston: He received the Distinguished Achievement Award of AASLD and the Distinguished Scientific Achievement Award of the American Liver Foundation, and delivered the Hans Popper Basic Science State-of-the-Art Lecture in Research. Dr. Friedman is the first individual to be honored in these ways at one meeting.

An internationally renowned physician-scientist, Dr. Friedman holds eight patents and has published more than 300 peer-reviewed publications. He formerly served as an Associate Editor of Hepatology and is currently a Scientific Advisor to Science Translational Medicine. He is also a past president of AASLD and a Fellow of the American Association for the Advancement of Science.

Under Dr. Friedman’s leadership, Mount Sinai’s Division of Liver Diseases has grown into the largest liver medicine program in the United States, incorporating the largest clinical liver fellowship training program in the country, a postdoctoral fellowship training grant supported by the National Institutes of Health (NIH), and a National Cancer Institute-sponsored Liver Cancer Program under The Tisch Cancer Institute at Mount Sinai.

Dr. Friedman’s additional past honors and awards include the European Association for the Study of Liver Diseases International Recognition Award, the Falk Foundation’s International Hans Popper Award, the Shanghai Magnolia Gold Award, the China Friendship Award, and Mount Sinai’s Jacobi Medallion.

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the “Honor Roll” of best hospitals in America, ranked No. 15 nationally in the 2016-2017 “Best Hospitals” issue of U.S. News & World Report.  The Mount Sinai Hospital is also ranked as one of the nation’s top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai West are ranked regionally. Mount Sinai’s Kravis Children’s Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in "Best Children's Hospitals."

For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

# # #